BKM120+Abiraterone Acetate for Metastatic CRPC

NCT01741753 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Due to slow accrual the supllier of BKM120 asked we cease further enrollment.

Conditions

Prostate Cancer

Interventions

DRUG: BKM120
DRUG: Abiraterone
DRUG: Prednisone

Sponsor

Dana-Farber Cancer Institute